𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prostaglandin E2 pathway in head and neck squamous cell carcinoma

✍ Scribed by Mercedes Camacho; Xavier León; María-Teresa Fernández-Figueras; Miquel Quer; Luis Vila

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
130 KB
Volume
30
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

Prostaglandin E~2~ (PGE~2~) is involved in malignant growth. The objective was to study the PGE~2~ pathway in head and neck squamous cell carcinoma (HNSCC) patients.

Methods.

Expression of cyclooxygenase (COX) and PGE‐synthase isoenzymes, and PGE‐receptors was determined in biopsies from 83 patients with HNSCC by real‐time reverse transcriptase–polymerase chain reaction (RT‐PCR).

Results.

Expression of COX‐2 and cytosolic‐PGE‐synthase was significantly increased, about 4‐fold and 2.5‐fold, respectively, in tumors versus paired nontumoral mucosa (n = 34). EP‐1 was the only PGE‐receptor significantly overexpressed in tumor samples. Expression of COX‐1 correlated with mPGES‐2 and COX‐2 correlated with mPGES‐1 (n = 83).

Conclusions.

COX‐2, functionally coordinated with mPGES‐1, is likely to be the limiting enzyme in PGE~2~ biosynthesis in HNSCC. The biological meaning of cPGES/p23 overexpression in HNSCC is not yet clear. Our results support the notion that mPGES‐1, cPGES, and EP‐1 could be the targets for the development of specific PGE~2~‐modifier drugs for HNSCC treatment that could avoid negative side effects of COX‐2 selective inhibitors. © 2008 Wiley Periodicals, Inc. Head Neck 2008

📜 SIMILAR VOLUMES

Head and neck squamous cell carcinoma in
Head and neck squamous cell carcinoma in childhood
✍ de Carvalho, Marcos Brasilino; Sobrinho, Josias de Andrade; Rapoport, Abrão; Fav 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Background: Squamous cell carcinoma (scc) of the head and neck region is rare in young patients and even less frequent in children 15 years or younger children. the patients reported in the literature are isolated cases and their management is always difficult because there is no large experienc

Head and neck squamous cell carcinoma in
Head and neck squamous cell carcinoma in FAMMM syndrome
✍ Vladimir Vinarsky; Robert L. Fine; Adel Assaad; Ying Qian; John A. Chabot; Glori 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 2 views

## Abstract ## Background Germline mutations at the __INK4a/p16__ locus are implicated in several human cancer syndromes, including familial atypical multiple mole melanoma (FAMMM) syndrome, FAMMM‐pancreatic cancer (FAMMM‐PC) syndrome, and in familial head and neck cancer syndrome. ## Methods We

MicroRNA alterations in head and neck sq
MicroRNA alterations in head and neck squamous cell carcinoma
✍ Steven S. Chang; Wei Wen Jiang; Ian Smith; Luana M. Poeta; Shahnaz Begum; Chad G 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 244 KB 👁 1 views

## Abstract MicroRNAs (mirs) are small noncoding RNA molecules (∼22 nucleotides) that regulate posttranscriptional gene expression. Currently, there has not been a comprehensive study of their role in primary head and neck squamous cell carcinoma (HNSCC). To determine the role of mirs in HNSCC, we

Dairy products, leanness, and head and n
Dairy products, leanness, and head and neck squamous cell carcinoma
✍ Edward S. Peters; Brian G. Luckett; Katie M. Applebaum; Carmen J. Marsit; Michae 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract ## Background. As part of a population‐based case–control study, we investigated the association of food groups and micronutrients estimated from a validated food frequency questionnaire (FFQ) with the risk of development of head and neck squamous cell carcinoma (HNSCC). ## Methods.

Human papillomavirus 16 and head and nec
Human papillomavirus 16 and head and neck squamous cell carcinoma
✍ C. Sloane Furniss; Michael D. McClean; Judith F. Smith; Janine Bryan; Heather H. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 101 KB 👁 1 views

## Abstract Evidence suggests that human papillomavirus (HPV)16 seropositivity reflects past HPV16 exposure and is associated with risk for head and neck squamous cell carcinoma (HNSCC). Our objectives were to test the hypothesis that HPV16 seropositivity is associated with risk for HNSCC, to corre